Pentostatin and General physical health deterioration - a phase IV clinical study of FDA data
General physical health deterioration is found among people who take Pentostatin, especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Pentostatin and have General physical health deterioration. It is created by eHealthMe based on reports of 804 people who have side effects when taking Pentostatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
804 people reported to have side effects when taking Pentostatin.
Among them, 18 people (2.24%) have General physical health deterioration.
What is Pentostatin?
Pentostatin has active ingredients of pentostatin. eHealthMe is studying from 786 Pentostatin users for its effectiveness, alternative drugs and more.
What is General physical health deterioration?
General physical health deterioration (weak health status) is found to be associated with 3,085 drugs and 2,821 conditions by eHealthMe.
Number of Pentostatin and General physical health deterioration reports submitted per year:
Time on Pentostatin when people have General physical health deterioration *:
Gender of people who have General physical health deterioration when taking Pentostatin*:
Age of people who have General physical health deterioration when taking Pentostatin *:
Common drugs people take besides Pentostatin *:
Common side effects people have besides General physical health deterioration *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Pentostatin and have General physical health deterioration?Check whether General physical health deterioration is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was General physical health deterioration and when was it recovered:
Expand to all the drugs that have ingredients of pentostatin:
Alternative drugs to, pros and cons of Pentostatin:
- Pentostatin (786 reports)
General physical health deterioration treatments and more:
- General physical health deterioration (107,022 reports)
COVID vaccines that are related to General physical health deterioration:
- General physical health deterioration in Moderna COVID Vaccine
- General physical health deterioration in Pfizer BioNTech Covid Vaccine
- General physical health deterioration in Johnson and Johnson Covid Vaccine
Common drugs associated with General physical health deterioration:
- Prednisone: 6,536 reports
- Methotrexate: 5,829 reports
- Pantoprazole: 5,381 reports
- Humira: 4,779 reports
- Ibuprofen: 4,541 reports
- Aspirin: 4,322 reports
- Yaz: 4,304 reports
- Yasmin: 4,111 reports
- Ramipril: 3,896 reports
- Zometa: 3,670 reports
All the drugs that are associated with General physical health deterioration:
- General physical health deterioration (3,085 drugs)
Common conditions associated with General physical health deterioration:
- High blood pressure: 5,602 reports
- Rheumatoid arthritis: 5,181 reports
- Pain: 4,102 reports
- Parkinson's disease: 3,754 reports
- Multiple sclerosis: 3,427 reports
All the conditions that are associated with General physical health deterioration:
- General physical health deterioration (2,821 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pentostatin (the active ingredients of Pentostatin) and Pentostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Niaspan and Balsalazide Disodium drug interaction - now
- Augmentin and Sleep Disorder - 3 seconds ago
- Risperdal and Seroquel drug interaction - 6 seconds ago
- Colestid and Food Allergy - 6 seconds ago
- Promacta and Ibuprofen drug interaction - 7 seconds ago
- Ritalin and Small Intestinal Obstruction - 7 seconds ago
- Azacitidine and Nebupent drug interaction - 25 seconds ago
- Zomig and Sulfamethoxazole And Trimethoprim drug interaction - 28 seconds ago
- Albuterol and Ductus Arteriosus Premature Closure - 28 seconds ago
- Piperacillin And Tazobactam and Pain - 28 seconds ago